Guidelines for the clinical evaluation of anticonvulsant drugs (adults and children).

LDR			01199nam a22002891i 4500
001			000090705
003			MiAaHDL
005			20220528000000.0
006			m d
007			cr bn ---auaua
008			880715s1977 mdu b f00010 eng d
035	⊔	⊔	‡a(MiU)990000907050106381
035	⊔	⊔	‡asdr-miu.990000907050106381
035	⊔	⊔	‡z(MiU)MIU01000000000000000090705-goog
035	⊔	⊔	‡a(OCoLC)6915447
035	⊔	⊔	‡a(CaOTULAS)160063997
035	⊔	⊔	‡a(RLIN)MIUG3585590-B
035	⊔	⊔	‡z(MiU)Aleph000090705
040	⊔	⊔	‡aDHEW ‡cDHEW ‡dTxHMC ‡dISUM ‡dDGPO ‡dMiU ‡dCStRLIN
110	1	⊔	‡aUnited States. ‡bFood and Drug Administration. ‡bBureau of Drugs.
245	1	0	‡aGuidelines for the clinical evaluation of anticonvulsant drugs (adults and children).
260	⊔	⊔	‡aRockville, Md. : ‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ; ‡aWashington : ‡bfor sale by the Supt. of Docs., U.S. Govt. Print. Off., ‡c1977.
300	⊔	⊔	‡aiii, 9 p. ; ‡c27 cm.
490	0	⊔	‡aDHEW publication ; no. (FDA) 77-3045
490	0	⊔	‡aFDA Bureau of Drugs clinical guidelines
538	⊔	⊔	‡aMode of access: Internet.
650	⊔	2	‡aDrug Evaluation
650	⊔	2	‡aAnticonvulsants
650	⊔	0	‡aAnticonvulsants
650	⊔	0	‡aDrugs ‡xTesting
899	⊔	⊔	‡a39015003209262
CID	⊔	⊔	‡a000090705
DAT	0	⊔	‡a19880715000000.0 ‡b20220528000000.0
DAT	1	⊔	‡a20220529234014.0 ‡b2025-02-18T18:30:40Z
DAT	2	⊔	‡a2025-02-18T18:30:02Z
CAT	⊔	⊔	‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT	⊔	⊔	‡aBK
HOL	⊔	⊔	‡0sdr-miu.990000907050106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015003209262 ‡sMIU ‡1990000907050106381
974	⊔	⊔	‡bMIU ‡cMIU ‡d20250218 ‡sgoogle ‡umdp.39015003209262 ‡y1977 ‡rpd ‡qbib ‡tUS fed doc